Hologic Acquires Acessa Health for Approximately $80M

Haemonetics Acquires Vivasure Medical

January 11, 2026

Medical Devices

Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.

Solventum Completes Acquisition of Acera Surgical

December 23, 2025

Healthcare Services

Solventum completed its acquisition of Acera Surgical, a privately held bioscience company focused on regenerative wound care. The deal includes $725 million in upfront cash plus up to $125 million in contingent cash payments tied to future milestones.

Blackstone and TPG Acquire Hologic in $18.3B Take-Private

October 22, 2025

Medical Devices

Hologic agreed to be acquired by funds managed by Blackstone and TPG in a transaction valued at up to $79 per share and approximately $18.3 billion enterprise value. The deal provides $76 per share in cash plus a non-tradable contingent value right (CVR) worth up to $3 per share tied to Breast Health revenue milestones in fiscal 2026 and 2027.

Hologic Acquires Gynesonics

January 6, 2025

Medical Devices

Hologic, Inc. completed its previously announced acquisition of Gynesonics, a privately held medical device company focused on minimally invasive solutions for women’s health, for about $350 million. Gynesonics develops the Sonata System for diagnostic intrauterine imaging and incision-less transcervical treatment of certain symptomatic uterine fibroids.

Access Healthcare Acquires Envera Health

October 12, 2023

Healthcare Services

Access Healthcare, a global revenue cycle management provider based in Dallas, has acquired Envera Health, a U.S.-based patient engagement services company. The deal expands Access Healthcare's end-to-end RCM capabilities by adding omnichannel patient engagement and managed services to its technology-enabled offerings.

Hologic, Inc. Acquires Mobidiag Oy

June 17, 2021

Medical Devices

Hologic, Inc. has completed the acquisition of Mobidiag Oy, a Finnish developer of near‑patient molecular diagnostic instruments and tests, for approximately $808 million. The deal expands Hologic's diagnostics capabilities by adding Mobidiag's Amplidiag and Novodiag platforms for rapid, multiplexed acute‑care testing and broadens Hologic's global diagnostics footprint.